Get tips and insights from health-care professionals and people with diabetes, share your thoughts, and ask questions on our blog.
- Tara Dairman
- Katharine Davis
- Maryam Elarbi
- Joe Eldridge
- Gabrielle Kaplan-Mayer
- Eric Lagergren
- Mark Marino
- Joe Nelson
- Andy Stuckey
- Alternative Medicine/ Complementary Therapies
- Blood Glucose Monitoring
- Dental Health
- Diabetes News
- Diabetes Research
- Diabetic Complications
- Diagnosis
- Emotional Health
- Exercise
- Eyes & Vision
- Foot Care
- General Diabetes & Health Issues
- Heart Health
- High Blood Glucose
- Insulin & Other Injected Drugs
- Kids & Diabetes
- Living With Diabetes
- Low Blood Glucose
- Men's Health
- Money Matters
- Nutrition & Meal Planning
- Oral Medicines
- Sexual Health
- Tools & Technology
- Traveling With Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Weight Loss
- What We're Reading
- Women's Health
Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.
Links to help you learn more about diabetes.
Ask a diabetes expert
Other diabetes resources
Browse article topics
Statin May Reduce Benefits of Exercise
The generic cholesterol-lowering drug simvastatin, previously sold under the brand name Zocor, may diminish the positive effects of exercise in overweight and obese adults, according to a small new study from the University of Missouri…
Metformin May Delay Aging Process
The oral diabetes drug metformin may slow the aging process by mimicking the effects of a calorie-restricted diet, according to a new animal study from the United Kingdom…
First-in-Class Drug for Type 2
On March 29, the US Food and Drug Administration (FDA) approved the diabetes drug Invokana (generic name canagliflozin) for use, in conjunction with a healthful diet and physical activity, in adults with Type 2 diabetes. It is the first drug in a new class of medicines known as sodium glucose co-transporter 2 (SGLT2) inhibitors…
Three New Drugs for Type 2 Diabetes Approved
On January 26, pharmaceutical manufacturer Takeda announced the approval of its Type 2 diabetes drug, Nesina (generic name alogliptin) by the US Food and Drug Administration (FDA). It is the fourth drug to join a class of medicines known as DPP-4 inhibitors…
Drugs for Diabetes Pain
Pain researcher Rebecca Sudore, MD, says, “Adults living with Type 2 diabetes are suffering from incredibly high rates of pain, at levels similar to patients living with cancer.” Sounds awful. But what can we do about it? Actually, quite a bit…
Metformin Without the Misery
What if you could get all the benefits of metformin, but without the abdominal pain, diarrhea, gas, and vomiting that this medicine often brings? Well, such a treatment exists, and it works. Why hasn’t it come to market?
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
